Antifungal Agents
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Dosage Regimen: Fixed Dose
Hepatic Drug Excretion: Enterohepatic Cycling
Anthelminthic Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 22, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
1Tufts University School of Medicine, 36 Harrison Avenue, Boston, MA, 02111, USA.
No abstract available in PubMed .